Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
0.6840
-1.2460 (-64.56%)
At close: Nov 11, 2026, 4:00 PM EST
0.6834
-0.0006 (-0.09%)
After-hours: Nov 11, 2026, 7:59 PM EST
Company Description
Basel Medical Group Ltd provides healthcare services in Singapore.
The company offers general and subspecialized orthopedic, trauma, sports medicine, knee and hip replacements, sports medicine/surgery, foot/ankle surgery, and physiotherapy services, minimally invasive orthopedic procedures, as well as neurology and neurosurgical treatments.
It also provides health screening, mental health, woman’s health, and general practice services. In addition, the company’s services include consultation, medical diagnosis, and medical and surgical treatments.
Basel Medical Group Ltd was incorporated in 2023 and is headquartered in Singapore.
Basel Medical Group Ltd
| Country | Singapore |
| Founded | 2001 |
| IPO Date | Feb 25, 2025 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 82 |
| CEO | Yen Feng Chhoa |
Contact Details
Address: Gleneagles Medical Centre, Unit No. 02-10/11 Singapore, 258499 Singapore | |
| Phone | 65 6291 9188 |
| Website | baselmedical.com |
Stock Details
| Ticker Symbol | BMGL |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | SGD |
| IPO Price | $4.00 |
| CIK Code | 2004489 |
| CUSIP Number | G0864B111 |
| ISIN Number | VGG0864B1114 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Dr. Yen Feng Chhoa M.D. | Chief Executive Officer |
| Chun How Neo | Group Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2026 | 20-F | Annual and transition report of foreign private issuers |
| Oct 29, 2026 | 6-K | Report of foreign issuer |
| Oct 13, 2026 | 6-K | Report of foreign issuer |
| Oct 9, 2026 | 6-K | Report of foreign issuer |
| Oct 8, 2026 | 424B4 | Prospectus |
| Sep 29, 2026 | EFFECT | Notice of Effectiveness |
| Sep 23, 2026 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Sep 17, 2026 | F-1 | Registration statement for certain foreign private issuers |
| Sep 2, 2026 | 6-K | Report of foreign issuer |
| Aug 10, 2026 | 6-K | Report of foreign issuer |